Dr. Jeffrey R. Jay, M.D.

Great Point Partners as of Sept. 30, 2017

Portfolio Holdings for Great Point Partners

Great Point Partners holds 34 positions in its portfolio as reported in the September 2017 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Zogenix 12.9 $67M 1.9M 35.05
United Therapeutics Corporation (UTHR) 6.8 $35M 300k 117.19
Arena Pharmaceuticals 6.7 $35M 1.4M 25.50
Ptc Therapeutics I (PTCT) 6.1 $31M 1.6M 20.01
Concert Pharmaceuticals I equity 5.8 $30M 2.0M 14.75
Alnylam Pharmaceuticals (ALNY) 5.7 $29M 250k 117.49
Neurocrine Biosciences (NBIX) 5.7 $29M 475k 61.28
Foamix Pharmaceuticals 5.2 $27M 4.8M 5.55
Kura Oncology (KURA) 5.1 $26M 1.8M 14.95
Rigel Pharmaceuticals (RIGL) 4.5 $23M 9.1M 2.54
Dbv Technologies S A (DBVT) 3.7 $19M 451k 42.44
Global Blood Therapeutics In 3.4 $17M 561k 31.05
Selecta Biosciences (RNAC) 3.2 $17M 902k 18.25
Iovance Biotherapeutics (IOVA) 3.0 $16M 2.0M 7.75
Ignyta 3.0 $15M 1.2M 12.35
Aimmune Therapeutics 2.4 $12M 500k 24.79
Sarepta Therapeutics (SRPT) 2.2 $11M 250k 45.36
Synergy Pharmaceuticals 1.9 $9.5M 3.3M 2.90
Vanda Pharmaceuticals (VNDA) 1.7 $8.9M 498k 17.90
BioCryst Pharmaceuticals (BCRX) 1.7 $8.6M 1.6M 5.24
Sage Therapeutics (SAGE) 1.3 $6.8M 110k 62.30
Acceleron Pharma 1.2 $6.3M 170k 37.32
Bovie Medical Corporation 1.2 $6.2M 1.8M 3.38
Adamas Pharmaceuticals 1.1 $5.4M 256k 21.17
Seres Therapeutics (MCRB) 0.9 $4.4M 275k 16.04
Amarin Corporation (AMRN) 0.7 $3.7M 1.1M 3.50
Novocure Ltd ord (NVCR) 0.7 $3.5M 178k 19.85
Myovant Sciences 0.7 $3.5M 228k 15.47
Sunesis Pharmaceuticals Inc Ne 0.6 $2.8M 1.5M 1.94
Connecture 0.5 $2.8M 4.1M 0.67
Agile Therapeutics 0.3 $1.6M 363k 4.46
Ardelyx (ARDX) 0.1 $691k 123k 5.60
Streamline Health Solutions (STRM) 0.0 $191k 130k 1.47
Axovant Sciences 0.0 $67k 9.7k 6.92